NK-cell lymphomas are invariably associated with clonal Epstein–Barr virus infection in the tumor cells. Pathologically, NK-cell lymphomas are divided into extranodal NK-/T-cell lymphoma ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Researchers identified a monocyte/dendritic cell response to EBV reactivation in B cells as one of the earliest events in ...

A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune ...

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

"Our research shows that targeting USP7 effectively stops EBV-positive cell growth in preclinical models. Considering that several USP7 inhibitors not only exist but are also approved by the FDA ...